10
Jul
2023
Lessons Learned from the Intense Back-and-Forth Over a $1B Acquisition
Since 2018, about 90 biotech companies have been acquired for more than $500 million. That’s only about 15 to 20 companies per year, a tiny fraction of the approximately 10,000 biotechnology companies around the world. I was privileged to be part of one of those transactions, the sale of Albireo Pharma to Ipsen in January for $952 million upfront, plus... Read More